These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 18218563)

  • 1. Evaluation of Tc-99m (V) DMSA binding to human plasma proteins.
    Lee BF; Yeh JL; Chiu NT; Liu GC; Yu HS; Wang MH; Shen LH
    Kaohsiung J Med Sci; 2008 Jan; 24(1):1-9. PubMed ID: 18218563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections.
    Koukouraki S; Gaitanis I; Hatjipaulou A; Karkavitsas N
    Hell J Nucl Med; 2006; 9(2):99-102. PubMed ID: 16894413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of Tc-99m (V) dimercaptosuccinic acid in detecting intra-abdominal infection: compared with gallium scan.
    Lin WY; Hung GU; Chao TH
    Ann Nucl Med; 2007 Jul; 21(5):285-91. PubMed ID: 17634846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The visualization of pulmonary tuberculosis with Tc-99m (V) DMSA and Tc-99m citrate in comparison to Ga-67 citrate.
    Gulaldi NC; Bayhan H; Ercan MT; Kibar M; Oztürk B; Oğretensoy M; Bekdik CF
    Clin Nucl Med; 1995 Nov; 20(11):1012-4. PubMed ID: 8565355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soft-tissue tumors: diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy.
    Kobayashi H; Sakahara H; Hosono M; Shirato M; Endo K; Kotoura Y; Yamamuro T; Konishi J
    Radiology; 1994 Jan; 190(1):277-80. PubMed ID: 8259419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal uptake of 99mTc-dimercaptosuccinic acid is dependent on normal proximal tubule receptor-mediated endocytosis.
    Weyer K; Nielsen R; Petersen SV; Christensen EI; Rehling M; Birn H
    J Nucl Med; 2013 Jan; 54(1):159-65. PubMed ID: 23232279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tc-99m(V)-DMSA in wound infection after closure of an ileostomy.
    Chang MZ; Tsai CC; Hung GU; Lin WY
    Ann Nucl Med; 2005 Dec; 19(8):733-6. PubMed ID: 16445002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled L-lysine for tumor imaging.
    Karacalioglu AO; Yang DJ; Azhdarinia A; Mendez R; Oh C; Kohanim S; Chanda M; Greenwell AC; Yu DF; Kim EE
    Acad Radiol; 2006 Nov; 13(11):1327-37. PubMed ID: 17070450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multidrug resistance of in vitro tumor cell lines derived from human breast carcinoma MCF-7 does not influence pentavalent technetium-99m-dimercaptosuccinic Acid uptake.
    Denoyer D; Perek N; Le Jeune N; Frère D; Dubois F
    Cancer Biother Radiopharm; 2003 Oct; 18(5):791-801. PubMed ID: 14629827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.
    Wang SJ; Lin WY; Wey SP; Shen LH; Ting G
    Neoplasma; 1999; 46(4):246-8. PubMed ID: 10613606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ga-67 and Tc-99m (V) DMSA imaging in non-Hodgkin's lymphoma with amyloid tumor.
    Ohta H; Arima N; Hama Y; Doi S; Nasi K; Komibuchi T; Shintaku M
    Clin Nucl Med; 1995 Nov; 20(11):998-9. PubMed ID: 8565385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The study on the in-vitro stability of Tc(V)-99m dimercaptosuccinic acid].
    Lee BF; Chung KL; Jong SB; Yang CC; Chen CL; Chen YJ; Chen SL; Yu HS; Ting G; Shen LH
    Kaohsiung J Med Sci; 1996 Sep; 12(9):495-502. PubMed ID: 8819352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of drug transporters involved in the urinary secretion of [
    Kobayashi M; Mizutani A; Okamoto T; Muranaka Y; Nishi K; Nishii R; Shikano N; Nakanishi T; Tamai I; Kleinerman ES; Kawai K
    Nucl Med Biol; 2021; 94-95():92-97. PubMed ID: 33609918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic)acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment.
    Shukla J; Bandopadhyaya GP; Varma IK; Kumar R; Maulik SK
    Hell J Nucl Med; 2007; 10(1):9-13. PubMed ID: 17450243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective study.
    Shinya T; Sato S; Kunisada T; Inai R; Yanai H; Ozaki T; Kanazawa S
    Nucl Med Commun; 2015 Aug; 36(8):802-7. PubMed ID: 25932541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of 99mTc-DMSA(III) and 99mTc-nanocolloid in different syringes affects imaging quality.
    Bauwens M; Pooters I; van der Pol J; Mottaghy FM; van Kroonenburgh M
    Nucl Med Commun; 2014 Apr; 35(4):433-7. PubMed ID: 24569706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors.
    Yee CA; Lee HB; Blaufox MD
    J Nucl Med; 1981 Dec; 22(12):1054-8. PubMed ID: 6273511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
    Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
    Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
    Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
    Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.